PDCD1 and glioblastoma: Even within the profoundly immunosuppressive GBM TME, the BiTE achieved >60% in-vitro tumor-cell lysis, and its activity was retained despite T-cell exhaustion markers (PD-1, TIM-3, Lag-3) or concomitant glucocorticoids, indicating functional stability and resistance to exhaustion 100, 101.